Deals
Merck to take on superbugs with Cubist Pharma buy
Merck & Co Inc (MRK.N) said it would buy Cubist Pharmaceuticals Inc (CBST.O) for $8.4 billion plus assumption of debt, giving the major drugmaker an entry into the market for drugs that combat so-called superbugs.
Australian tech listing boom raises red flags
Australia is experiencing a record-shattering boom in technology listings as start-ups starved of venture capital funding pursue backdoor listings, a trend that has regulators concerned companies are trying to take short cuts to get to market.
Temasek buys stake in U.S. electronic trading firm Virtu
Singapore state investor Temasek Holdings has agreed to buy a minority stake in Virtu Financial Inc, the New York-based electronic dealing firm said on Monday, in a bet on the growth of automated trading globally.
KIA, Och-Ziff others pledge $2 billion for Dalian Wanda's up to $3.86 billion IPO
Kuwait Investment Authority (KIA) and Och-Ziff Capital Management Group Ltd (OZM.N) are among the group of 11 investors that have committed about $2 billion towards Dalian Wanda Commercial Properties Co Ltd's Hong Kong initial public offering (IPO), a person with direct knowledge of the matter told Reuters.